Latest News
Helix Technologies, MOR Analytics to Combine to Form Forian to Operate in Healthcare and Cannabis Industries
Tuesday 20 October 2020

US-based Medical Outcomes Research Analytics, LLC (MOR Analytics) has agreed to combine with US-based Helix Technologies, Inc. (OTCQB: HLIX) to form a healthcare information, analytics and technology organisation for the healthcare and cannabis industries, the company said.

Upon completion of the all-stock transaction, MOR Analytics members will own approximately 72% and Helix shareholders will own approximately 28% of the combined company on a fully diluted basis.

Helix shareholders will receive .027 shares of Forian common stock for each share of Helix common stock.

At the time of the combination, it is expected that Forian will have in excess of USD 10m in cash available.

Forian will not incur any new debt to affect the combination.

The combination forms the nation's only HIPAA compliant, Real World Evidence platform integrating cannabis and de-identified healthcare data designed to support SaaS based business performance analytics, product safety and efficacy surveillance solutions, and evidence-based health outcomes research.

Helix's legal advisors are Nelson Mullins Riley and Scarborough LLP. MOR Analytics' legal advisors are Duane Morris LLP.

Helix Technologies' compliance and point of sale technologies are tailored to the needs of the cannabis industry, offering customers compliance management solutions and earning government contracts.

MOR Analytics is developing a Real World Evidence (RWE) and Software as a Service (SaaS) analytics platform designed to support the information requirements of constituents across the healthcare industry.
Date Published: 20/10/2020